Sisram Medical Announces Upcoming FY2024 Financial Results Call

Sisram Medical to Share Financial Insights for FY 2024
Sisram Medical Ltd, recognized by its stock code 1696.HK, is preparing to unveil its financial results for FY 2024, marking the end of a significant financial year on December 31. The results will be made public on March 19, showcasing the Company’s commitment to transparency and engagement with its stakeholders.
Conference Call Scheduled for March 20
The management team at Sisram is keen to discuss these financial outcomes and is scheduled to hold a conference call on March 20 at 8:00 a.m. Eastern Time. This session aims to provide clarity and insights into the fiscal performance of the Company. Attendees will be given the opportunity to engage in a Q&A session following the prepared remarks.
Meet the Leadership Team
During the conference call, key leaders from Sisram Medical will address the audience. This includes Mr. Liu Yi, Chairman; Mr. Lior Dayan, Chief Executive Officer; Mr. Jiahong Li, Chief Financial Officer; Mr. Doron Yannai, CFO of Alma; and Ms. Qianli Fang, Secretary of the Board. Their participation underscores the Company’s dedication to sharing information directly from those at the forefront of its operations.
How to Participate
For those wishing to join the webinar, it is essential to register in advance to secure a spot. Registration can be completed through a straightforward process that will provide you with a confirmation email and guidelines for joining the session. It’s an excellent chance for investors and interested parties to gain insights directly from the leadership.
Replays and Continuous Engagement
For anyone unable to join the live session, Sisram Medical will offer a replay of the conference call on its investor relations page. This reflects the Company’s commitment to ensuring that stakeholders remain informed about its performance and strategy.
About Sisram Medical Ltd
Sisram Medical Ltd is distinguished as a global consumer wellness group that is at the forefront of developing a unique ecosystem combining innovative business models with consumer-focused branding. With a primary focus on energy-based devices and injectables, Sisram aims to enhance the quality of life for its users. It is majority-owned by Fosun Pharma, a notable healthcare leader in China. The Company celebrated its public listing on the Main Board of the Hong Kong Exchange back in September 2017, marking a significant milestone in its journey.
Frequently Asked Questions
What date is Sisram Medical releasing its FY2024 financial results?
Sisram Medical will release its FY2024 financial results on March 19.
When will the conference call take place?
The conference call is scheduled for March 20 at 8:00 a.m. Eastern Time.
Who will be speaking during the conference call?
The call will feature key executives, including Mr. Liu Yi and Mr. Lior Dayan, among others.
How can I participate in the conference call?
You need to register in advance to join the webinar for the conference call.
Where can I find the replay of the conference call?
The replay will be available on Sisram Medical's investor relations events page.
About The Author
Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.